• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    IOL Chemicals and Pharmaceuticals Limited — Board Meeting, 11-02-2026: Outcome of Board Meeting

    11-02-2026 | 02:47 pm

    IOL Chemicals & Pharma's board approved Q3 FY26 consolidated financial results. Revenue hit ₹580.39 Cr, Net Profit ₹20.58 Cr. An interim dividend of ₹1/share was declared (Record Date: Feb 17). The company also formed a new UK subsidiary, IOL Pharmaxis UK Limited.

    No comments yet. Be the first to comment!

    All announcements from IOL Chemicals and Pharmaceuticals Limited